Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Shanghai Henlius Biotech Co. Ltd.

https://www.henlius.com/en/index.html

Latest From Shanghai Henlius Biotech Co. Ltd.

Henlius Gets Fourth Chinese Biosimilar With Bevacizumab Nod

Shanghai Henlius Biotech has celebrated its fourth Chinese biosimilar approval with the NMPA’s endorsement of its bevacizumab biosimilar. The company is also working on an ophthalmic version to treat wAMD.

Biosimilars Approvals

Stringent Regulations Hinder International Trials In China: Trade Groups

Any delays caused by unpredictable regulatory reviews related to the export of genetic materials threaten to derail the inclusion of China in international clinical trials, caution two trade groups representing the pharma industry in the country.

China Clinical Trials

Henlius Doses First Patient In China For Ophthalmic Bevacizumab

Chinese firms Shanghai Henlius Biotech and Essex Bio-Technology have announced a key milestone in their Chinese Phase I clinical study for the HLX04-O biosimilar bevacizumab candidate to treat wet age-related macular degeneration.

Biosimilars Clinical Trials

Henlius Bevacizumab Trials Results Get International Recognition

China’s Henlius has received international recognition of Phase I and III clinical trial results for its bevacizumab biosimilar, HLX04, providing “strong evidence for the efficacy and safety similarity between HLX04 and the reference bevacizumab.” The company has submitted its NDA for the product to the NMPA for various indications.

Biosimilars Clinical Trials
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Vaccines
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Other Names / Subsidiaries
    • Fosun Pharma
    • Henlius Biopharmaceuticals
    • Shanghai Henlius Biotech, Inc.
    • Taiwan Henlix Biotech Co., Ltd.
    • Hengenix Biotech
UsernamePublicRestriction

Register